BIOC - Biocept, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
4,604
3,250
5,069
3,223
Cost of Revenue
10,541
10,052
9,345
6,920
Gross Profit
-5,936
-6,801
-4,276
-3,697
Operating Expenses
Research Development
4,824
4,469
3,365
2,713
Selling General and Administrative
12,584
12,989
13,534
11,615
Total Operating Expenses
17,408
17,457
16,898
14,328
Operating Income or Loss
-23,344
-24,259
-21,175
-18,025
Interest Expense
-
311
-
-
Total Other Income/Expenses Net
-
-
51
154
Income Before Tax
-25,437
-24,570
-21,606
-18,397
Income Tax Expense
1
2
8
2
Income from Continuing Operations
-25,438
-24,572
-21,614
-18,399
Net Income
-25,438
-24,572
-21,614
-18,399
Net Income available to common shareholders
-25,538
-25,208
-21,614
-18,399
EBITDA
-
-24,259
-21,175
-18,025